You have 9 free searches left this month | for more free features.

Dose Intensity

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Indianapolis (Fludarabine + Total Marrow

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Fludarabine + Total Marrow Irradiation
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
Jun 1, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Ann Arbor (Cisplatin, Carboplatin, IMRT (Intensity-Modulated Radiation

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Ann Arbor, Michigan
  • +1 more
Dec 20, 2022

High Grade Sarcoma Trial in Tampa (Intensity Modulated Radiation Therapy (IMRT), MRI)

Recruiting
  • High Grade Sarcoma
  • Intensity Modulated Radiation Therapy (IMRT)
  • MRI
  • Tampa, Florida
    Moffitt Cancer Center
Aug 16, 2022

Graves Disease Trial in Hong Kong (Echopulse)

Completed
  • Graves Disease
  • Echopulse
  • Hong Kong, Hong Kong
    Queen Mary Hospital
May 17, 2022

Hematologic Malignancies Trial in Baltimore (drug, radiation, procedure)

Recruiting
  • Hematologic Malignancies
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 14, 2022

Pancreas Adenocarcinoma Trial in Detroit, Milwaukee (CPI-613® (Dose level -1.0 250 mg/m^2), CPI-613® (Dose level 1.0 500

Recruiting
  • Pancreas Adenocarcinoma
  • CPI-613® (Dose level -1.0 250 mg/m^2)
  • +6 more
  • Detroit, Michigan
  • +1 more
Nov 9, 2022

Substance Use Disorders Trial in Trondheim (High dose training, low dose training)

Recruiting
  • Substance Use Disorders
  • High dose training
  • low dose training
  • Trondheim, Norway
    Klinikk for rus- og avhengighetsmedisin, St Olavs Hospital
Dec 16, 2021

GVHD Trial in Nantes (drug, radiation, other)

Terminated
  • Graft Versus Host Disease
  • Nantes, France
    Nantes Uh
Jul 13, 2022

Malignant Pleural Mesothelioma Trial in United States (Pembrolizumab, IMPRINT)

Recruiting
  • Malignant Pleural Mesothelioma
  • Basking Ridge, New Jersey
  • +6 more
Jul 13, 2022

Prostate Cancer Trial in Madison (radiotherapy)

Completed
  • Prostate Cancer
  • radiotherapy
  • Madison, Wisconsin
    University Of Wisconsin Hospital and Clinics
Aug 2, 2021

Nasopharyngeal Carcinoma Trial in Guangzhou (Intensity-modulated radiation therapy, Paclitaxel liposome, Cisplatin)

Active, not recruiting
  • Nasopharyngeal Carcinoma
  • Intensity-modulated radiation therapy
  • +3 more
  • Guangzhou, Guangdong, China
    Hai Qiang Mai
Aug 23, 2021

Chordoma of Spine, Chordoma of Sacrum, Chordoma of Base of Skull Trial in Boston, Houston (High Dose Intensity Modulated Proton

Active, not recruiting
  • Chordoma of Spine
  • +4 more
  • High Dose Intensity Modulated Proton Radiation
  • Boston, Massachusetts
  • +1 more
Sep 1, 2020

High-Intensity Interval Training, Body Composition, Performance Trial in Trikala (DoIT-1, DoIT-2, DoIT-3)

Completed
  • High-Intensity Interval Training
  • +3 more
  • DoIT-1
  • +3 more
  • Trikala, Greece
    Laboratory of Exercise Physiology, Exercise Biochemistry and Spo
Jan 4, 2022

Cervical Cancer Trial in Goyang-si,, Goyang-si (Tomotherapy)

Unknown status
  • Cervical Cancer
  • Tomotherapy
  • Goyang-si,, Gyeonggi-do, Korea, Republic of
  • +1 more
Sep 14, 2020

Meningioma, Brain Tumor Trial in Boston, Houston (Intensity Modulated Proton Therapy (IMPT))

Recruiting
  • Meningioma
  • Brain Tumor
  • Intensity Modulated Proton Therapy (IMPT)
  • Boston, Massachusetts
  • +1 more
Aug 17, 2020

Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial

Active, not recruiting
  • Acute Leukemia
  • +14 more
  • Duarte, California
    City of Hope Medical Center
Nov 18, 2022

Prostate Cancer Trial in Houston (Conventional Fractionated Intensity Modulated Radiotherapy, Hypofractionated Intensity

Active, not recruiting
  • Prostate Cancer
  • Conventional Fractionated Intensity Modulated Radiotherapy
  • Hypofractionated Intensity Modulated Radiotherapy
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 4, 2021

Metastatic Colorectal Cancer Trial in France (Trifluridine/Tipiracil)

Recruiting
  • Metastatic Colorectal Cancer
  • Amiens, France
  • +21 more
Jan 26, 2021

Glioblastoma, Adult Trial in France (Radiotherapy)

Recruiting
  • Glioblastoma, Adult
  • Radiotherapy
  • Amiens, France
  • +6 more
Mar 31, 2022

Soft Tissue Sarcoma Trial in United States (Intensity-modulated radiation therapy (IMRT))

Recruiting
  • Soft Tissue Sarcoma
  • Intensity-modulated radiation therapy (IMRT)
  • Basking Ridge, New Jersey
  • +6 more
May 16, 2022

Non Toxic Multinodular Goiter, High Intensity Focused Ultrasound, RAI Trial in Hong Kong (Echopulse, Radioactive iodine

Not yet recruiting
  • Non Toxic Multinodular Goiter
  • +2 more
  • Echopulse
  • Radioactive iodine (Radioidine i131)
  • Hong Kong, Hong Kong
    Queen Mary Hospital
Apr 27, 2021

Recurrent Lung Non-Small Cell Carcinoma, Stage II NSCLC AJCC v7, Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 Trial in

Recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • +5 more
  • Image Guided Radiation Therapy
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 15, 2021

Chronic Lymphocytic Leukemia Trial in Bayonne, Perpignan, Toulouse (Telephone Intervention, Usual Practice)

Completed
  • Chronic Lymphocytic Leukemia
  • Telephone Intervention
  • Usual Practice
  • Bayonne, France
  • +2 more
Jul 28, 2020

Refractory and/or Relapsed Metastatic Solid Tumors Trial in United States (Cyclophosphamide, Fludarabine, low dose total body

Recruiting
  • Refractory and/or Relapsed Metastatic Solid Tumors
  • Saint Petersburg, Florida
  • +4 more
Oct 29, 2021

Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Indianapolis (Fludarabine, Total Marrow

Terminated
  • Acute Myeloid Leukemia
  • +3 more
  • Indianapolis, Indiana
    Indiana University Melvin & Bren Simon Cancer Center
Feb 22, 2022